DAB2IP and Alzheimer disease: Our subset-based meta-analysis indicated locus 4 (lead SNP rs116426890, pASSET = 3.40e-13, ABI2), locus 13 (lead SNP rs10818576, pASSET = 3.49e-09, DAB2IP), locus 16 (lead SNP rs9787911, pASSET = 9.95e-09, NTM), locus 20 (lead SNP rs9630903, pASSET = 2.43e-08, FCHO1) and locus 22 (lead SNP rs1964272, pASSET = 6.62e-10, SNRPD2) to be potentially novel for AD with only rs116426890 reaching a nominal significance of p = 1.52e-06 in the Bellenguez et al. study (22).